Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Production of heterologous immune serums against human lymphocytes].

× No keyword cloud information.

28 in total

1. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

Authors: T E Starzl; T L Marchioro; K A Porter; Y Iwasaki; G J Cerilli
Journal: Surg Gynecol Obstet Date: 1967-02

2. Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin.

Authors: A M Denman; E J Denman; E J Holborow
Journal: Lancet Date: 1967-05-20 Impact factor: 79.321

3. Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum.

Authors: H L Currey; M Ziff
Journal: Lancet Date: 1966-10-22 Impact factor: 79.321

4. [Effect of a heterologous antilymphocyte serum on graft rejection in the dog].

Authors: R Pichlmayr
Journal: Klin Wochenschr Date: 1966-05-15

5. Further experiments on the action of antilymphocytic antiserum.

Authors: R H Levey; P B Medawar
Journal: Proc Natl Acad Sci U S A Date: 1967-08 Impact factor: 11.205

6. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].

Authors: R Pichlmayr; W Brendel; I Pichlmayr
Journal: Z Gesamte Exp Med Date: 1967

7. Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro.

Authors: M F Woodruff; B Reid; K James
Journal: Nature Date: 1967-08-05 Impact factor: 49.962

8. The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors: Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal: Surg Gynecol Obstet Date: 1967-01

9. Thoracic duct cannulation in man. I. Surgical technique and a clinical study on 79 patients.

Authors: B Werner
Journal: Acta Chir Scand Suppl Date: 1965

10. The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors: B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal: J Exp Med Date: 1961-12-01 Impact factor: 14.307

12 in total

1. [The importance of antilymphocyte serum in immunosuppression].

Authors: R Pichlmayr
Journal: Langenbecks Arch Chir Date: 1968

2. [In vitro demonstration of antilymphocytic and antigranulocytic antibodies by means of determination of leukocyte resistance].

Authors: J Schröder; H Schröder
Journal: Klin Wochenschr Date: 1969-03-01

10. [Recovery of anti-human lymphocyte serum from a horse immunized with leukemic lymphocytes and simultaneous administration of equine anti-human erythrocyte serum].

Authors: W Land; W Brendel; R Pichlmayr; E Wagner; G Beck; E Schmittdiel; H Stritzinger
Journal: Klin Wochenschr Date: 1970-06-15

[Production of heterologous immune serums against human lymphocytes].

1. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

2. Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin.

3. Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum.

4. [Effect of a heterologous antilymphocyte serum on graft rejection in the dog].

5. Further experiments on the action of antilymphocytic antiserum.

6. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].

7. Effect of antilymphocytic antibody and antibody fragments on human lymphocytes in vitro.

8. The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

9. Thoracic duct cannulation in man. I. Surgical technique and a clinical study on 79 patients.

10. The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

1. [The importance of antilymphocyte serum in immunosuppression].

2. [In vitro demonstration of antilymphocytic and antigranulocytic antibodies by means of determination of leukocyte resistance].

3. The effect of anti-lymphocyte globulin on human monocytes in vitro.

4. [Experimental studies on improving the specifitcity of antilymphocyte serum and its compatibility].

5. [Effect of antihuman lymphocyte globulin on human monocytes in vitro].

6. [In vitro test of the antilymphocyte serum (AS) using the leukocyte resistance test].

7. [Mitosis activity and chromosome analysis in peripheral lymphocytes of ALG-treated patients].

8. [Isolation of lymphocytes from human and animal blood].

9. [Antilymphocyte serum therapy in human autoimmune diseases].

10. [Recovery of anti-human lymphocyte serum from a horse immunized with leukemic lymphocytes and simultaneous administration of equine anti-human erythrocyte serum].